BioLargo, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
November 14, 2023 at 01:29 pm EST
Share
BioLargo, Inc. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported revenue was USD 2.67 million compared to USD 1.5 million a year ago. Net loss was USD 1.2 million compared to USD 0.504 million a year ago. Basic loss per share from continuing operations was USD 0.01.
For the nine months, revenue was USD 7.86 million compared to USD 3.79 million a year ago. Net loss was USD 2.78 million compared to USD 3.38 million a year ago. Basic loss per share from continuing operations was USD 0.01 compared to USD 0.01 a year ago.
BioLargo, Inc. is a cleantech and life sciences innovator and engineering services solution provider. The Company invents, develops, and commercializes platform technologies to solve challenging environmental problems like polyfluoroalkyl substances (PFAS) contamination, advanced water and wastewater treatment, industrial odor control, air quality control, infection control, and myriad environmental remediation challenges. The Companyâs segments include ONM Environmental, which manufactures and sells its odor and VOC control products and services, including its flagship product, CupriDyne Clean; BLEST, which provides professional engineering services supporting its internal business units; Clyra Medical, which develops and sells medical products based on its technology; BioLargo Canada, which is primary engaged in research and development activities; and Corporate Operations, which support the operating segments with legal, accounting, human resources, and other services.
BIOLARGO, INC. 
